CME Group Inc. $CME Shares Purchased by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 7.3% in the fourth quarter, Holdings Channel reports. The firm owned 3,074,773 shares of the financial services provider’s stock after buying an additional 208,318 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in CME Group were worth $839,659,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. SG Americas Securities LLC increased its position in shares of CME Group by 345.2% during the 4th quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock worth $64,965,000 after purchasing an additional 184,459 shares during the last quarter. Dover Advisors LLC increased its position in shares of CME Group by 95.5% during the 3rd quarter. Dover Advisors LLC now owns 5,597 shares of the financial services provider’s stock worth $1,512,000 after purchasing an additional 2,734 shares during the last quarter. FLC Capital Advisors acquired a new stake in shares of CME Group during the 4th quarter worth about $2,122,000. NEOS Investment Management LLC increased its position in shares of CME Group by 32.5% during the 3rd quarter. NEOS Investment Management LLC now owns 50,977 shares of the financial services provider’s stock worth $13,773,000 after purchasing an additional 12,503 shares during the last quarter. Finally, Lansforsakringar Fondforvaltning AB publ increased its position in shares of CME Group by 1.6% during the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 114,411 shares of the financial services provider’s stock worth $30,913,000 after purchasing an additional 1,777 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME announced four new E-mini futures contracts tied to broad-market equity benchmarks, plus new Micro E-mini options on the S&P 500 and Nasdaq-100. These launches could attract more trading volume by giving investors additional, lower-cost ways to hedge and gain market exposure. CME Group to Expand Equity Index Suite with Launch of Four New E-mini Futures Contracts
• Positive Sentiment: The company also said it will expand 24/7 trading for WTI crude oil and gold, which could improve price discovery and make CME’s metals and energy products more attractive to global traders operating outside normal market hours. CME Group to Expand 24/7 Trading for WTI Crude Oil and Gold
• Positive Sentiment: CME launched Nasdaq CME Crypto Index futures and is moving deeper into digital-asset derivatives, giving investors regulated exposure to major cryptocurrencies and potentially opening another growth avenue for the exchange. CME Group Launches Crypto Index Futures Tracking Bitcoin, Solana and XRP
• Neutral Sentiment: Erste Group Bank slightly raised its FY2026 EPS estimate for CME, signaling stable earnings expectations rather than a major change in outlook.
• Negative Sentiment: Some commentary around the CFTC’s crypto oversight has raised concerns about regulatory pressure and market criticism, which could create uncertainty for CME’s expanding crypto-related products. CFTC’s Lone Chair Selig Expands Grip Over Crypto and Prediction Markets

Analyst Upgrades and Downgrades

CME has been the subject of a number of recent analyst reports. Raymond James Financial raised their price objective on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research report on Monday, April 6th. Argus reissued a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Rothschild & Co Redburn upgraded CME Group from a “neutral” rating to a “buy” rating and raised their target price for the company from $316.00 to $323.00 in a report on Thursday. Jefferies Financial Group lowered their target price on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Finally, Barclays lowered their target price on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a report on Thursday, April 23rd. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $305.71.

Insider Activity

In other news, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares in the company, valued at approximately $2,397,597.04. This trade represents a 31.39% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the transaction, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 44,044 shares of company stock worth $13,297,507. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Performance

Shares of CME opened at $269.53 on Friday. The stock has a 50-day simple moving average of $284.79 and a 200-day simple moving average of $288.07. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $97.67 billion, a PE ratio of 23.00, a PEG ratio of 3.01 and a beta of 0.21. CME Group Inc. has a 1 year low of $244.56 and a 1 year high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.80 EPS. On average, analysts predict that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.